Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
With a new year swiftly coming, Steve Miranda, Executive Vice President, Applications Development at Oracle, recently joined the CRM Playaz to discuss what the year ahead has in store in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback